Treace Medical Concepts I...

NASDAQ: TMCI · Real-Time Price · USD
7.16
0.21 (3.02%)
At close: Aug 15, 2025, 2:19 PM

Treace Medical Concepts Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-55.74M -49.53M -42.81M -20.55M
Depreciation & Amortization
8.42M 5.35M 2.13M 685K
Stock-Based Compensation
30.6M 17.35M 8.11M 3.41M
Other Working Capital
-8.42M 6.24M 9.39M 4.19M
Other Non-Cash Items
4.99M 1.99M 7.73M 176K
Deferred Income Tax
n/a n/a n/a 419K
Change in Working Capital
-25.43M -9.74M -5.81M -1.33M
Operating Cash Flow
-37.17M -34.58M -30.65M -17.19M
Capital Expenditures
-11.59M -11.46M -14.84M -2.71M
Cash Acquisitions
n/a -20M 61.68M n/a
Purchase of Investments
-71.58M -169.87M -63.41M n/a
Sales Maturities Of Investments
118.55M 120.02M 1.73M n/a
Other Investing Acitivies
n/a n/a -61.68M n/a
Investing Cash Flow
35.38M -81.3M -76.52M -2.71M
Debt Repayment
n/a n/a 19.61M -1.79M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-268K -13K -989K n/a
Financial Cash Flow
160K 109.38M 20.81M 107.65M
Net Cash Flow
-1.63M -6.49M -86.36M 87.75M
Free Cash Flow
-48.76M -46.03M -45.49M -19.9M